3-iodobenzylguanidine has been researched along with Cardiac Toxicity in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Arrais, TR; Biolo, A; Cavalli, GD; Dos Santos, BT; Grossman, GB; Migliavaca, CB; Pereira, GB | 1 |
Verberne, HJ; Verschure, DO | 1 |
Amanullah, A; Gupta, S | 1 |
Andrade, LR; Brandão, SC; Guimarães, SL; Maia, RJ; Markman Filho, B | 1 |
Aragon, DC; da Rocha, ET; da Silva, ET; Dos Santos, MJ; Junior, JS; Verberne, HJ | 1 |
Elming, MB; Hasbak, P; Hutchings, M; Kjaer, A; Laursen, AH; Ripa, RS; Thune, JJ | 1 |
3 review(s) available for 3-iodobenzylguanidine and Cardiac Toxicity
Article | Year |
---|---|
MIBG cardiac imaging compared to ejection fraction in evaluation of cardiotoxicity: a systematic review.
Topics: 3-Iodobenzylguanidine; Anthracyclines; Cardiotoxicity; Heart; Humans; Stroke Volume; Ventricular Function, Left | 2022 |
Radionuclide imaging of cardiac sympathetic innervation in heart failure: unlocking untapped potential.
Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Cardiac Resynchronization Therapy; Cardiomyopathies; Cardiotoxicity; Death, Sudden, Cardiac; Ephedrine; Heart; Heart Conduction System; Heart Failure; Heart Transplantation; Humans; Prognosis; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2015 |
Topics: 3-Iodobenzylguanidine; Adrenergic Fibers; Animals; Anthracyclines; Antibiotics, Antineoplastic; Cardiomyopathies; Cardiotoxicity; Early Diagnosis; Heart; Humans; Iodine Radioisotopes; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Stroke Volume; Ventricular Function, Left | 2018 |
3 other study(ies) available for 3-iodobenzylguanidine and Cardiac Toxicity
Article | Year |
---|---|
Anthracycline-induced cardiotoxicity: Is there a role for myocardial
Topics: 3-Iodobenzylguanidine; Anthracyclines; Cardiotoxicity; Doxorubicin; Humans; Iodine Radioisotopes; Lymphoma; Radionuclide Imaging | 2020 |
Cardiac sympathetic hyperactivity after chemotherapy: early sign of cardiotoxicity?
Topics: 3-Iodobenzylguanidine; Adult; Age Factors; Aged; Anthracyclines; Antineoplastic Agents; Breast Neoplasms; Cardiotoxicity; Echocardiography, Doppler; Female; Heart; Heart Diseases; Heart Rate; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Statistics, Nonparametric; Stroke Volume; Sympathetic Nervous System; Trastuzumab | 2015 |
Assessment of late anthracycline-induced cardiotoxicity by
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Anthracyclines; Antineoplastic Agents; Autonomic Nervous System Diseases; Brazil; Cardiotoxicity; Causality; Child; Child, Preschool; Comorbidity; Female; Humans; Male; Neoplasms; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 2017 |